1356476-38-4Relevant articles and documents
Stereoselective Diboration of Spirocyclobutenes: A Platform for the Synthesis of Spirocycles with Orthogonal Exit Vectors
Nóvoa, Luis,Trulli, Laura,Parra, Alejandro,Tortosa, Mariola
supporting information, p. 11763 - 11768 (2021/04/26)
The diastereo- and enantioselective diboration of spirocyclobutenes provides a platform for the rapid preparation of a wide variety of chiral spirocyclic building blocks. The chemoselective functionalization of the carbon-boron bond in the products, including a stereospecific sp3-sp2 Suzuki–Miyaura cross-coupling reaction, provides a powerful tool to control the directionality and the nature of the exit vectors in the spirocyclic framework.
IRAK DEGRADERS AND USES THEREOF
-
Paragraph 00512; 001093-001095, (2021/06/26)
The present invention provides compounds, compositions thereof, and methods of using the same.
Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4. 5]decane as lead scaffolds
Meyers, Marvin J.,Long, Scott A.,Pelc, Matthew J.,Wang, Jane L.,Bowen, Scott J.,Walker, Mark C.,Schweitzer, Barbara A.,Madsen, Heather M.,Tenbrink, Ruth E.,McDonald, Joseph,Smith, Sarah E.,Foltin, Susan,Beidler, David,Thorarensen, Atli
scheme or table, p. 6538 - 6544 (2011/12/04)
Herein we report the identification of two new fatty acid amide hydrolase (FAAH) inhibitor lead series with FAAH kinact/Ki potency values greater than 1500 M-1s-1. The two novel spirocyclic cores, 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane, clearly distinguished themselves from the other spirocyclic cores on the basis of their superior potency for FAAH. Lead compounds from these two series have suitable FAAH potency and selectivity for additional medicinal chemistry optimization.